Walleye Capital LLC Biomarin Pharmaceutical Inc Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Walleye Capital LLC holds 155,442 shares of BMRN stock, worth $10.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

155,442

Previous 23,800 553.12%

Holding current value

$10.4 Million

Previous $1.96 Million 457.73%

% of portfolio

0.02%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $8.08 Million - $11 Million	117,119 Added 305.61%	155,442 $10.9 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $270,850 - $335,588	3,639 Added 10.49%	38,323 $3.16 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $1.85 Million - $2.19 Million	22,111 Added 175.86%	34,684 $3.03 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $577,137 - $745,917	7,572 Added 151.41%	12,573 $1.21 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $3.71 Million - $4.12 Million	-43,638 Reduced 89.72%	5,001 $442,000
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $7.68 Million - $8.89 Million	-88,633 Reduced 64.57%	48,639 $4.22 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $6.3 Million - $8.42 Million	71,798 Added 109.66%	137,272 $13.3 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $2.21 Million - $2.96 Million	-27,272 Reduced 29.41%	65,474 $6.78 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $4.31 Million - $5.09 Million	52,496 Added 130.42%	92,746 $7.86 Million
Q2 2022 Aug 08, 2022	SELL	$71.48 - $86.85 $5.39 Million - $6.55 Million	-75,399 Reduced 65.2%	40,250 $3.34 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $7.74 Million - $9.65 Million	104,154 Added 906.08%	115,649 $8.92 Million
Q4 2021 Mar 03, 2022	BUY	$71.72 - $91.47 $824,421 - $1.05 Million	11,495 New	11,495 $1.02 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $266,181 - $304,273	-3,560 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $206,746 - $232,155	2,738 Added 333.09%	3,560 $297,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $69,212 - $81,065	822 New	822 $73,000

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Biomarin Pharmaceutical Inc Transaction History